IMNM Market Cap History



Below is a table of the IMNM market cap history going back to 10/31/2020:

Date IMNM Market Cap
10/31/2020119.65M
3/22/2021398.78M
5/7/2021258.42M
8/12/2021168.12M
11/12/2021219.38M
3/22/202257.36M
5/9/202232.87M
8/2/202243.78M
11/10/202249.73M
5/1/202361.32M
8/7/202388.53M
11/7/2023380.72M
5/6/2024927.12M

Also see: IMNM Shares Outstanding History
and IMNM YTD Return
IMNM Historical Market Cap:
+79.05% CAGR
IMNM Historical Market Cap: +79.05% CAGR

Mouse over chart for data details
10/31/2020 ...5/6/2024
Immunome is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop antibody therapeutics designed to change the way diseases are being treated. Co.'s primary focus areas are oncology and infectious disease. Co. is advancing two programs: a three-antibody cocktail (IMM-BCP-01) for potential treatment and prophylaxis of SARS-CoV-2, and an antibody (IMM-ONC-01) against interleukin 38, an immune checkpoint, for the potential treatment of various solid tumors. We show 13 historical shares outstanding datapoints in our IMNM shares outstanding history coverage, used to compute IMNM market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMNM market cap history over the course of time is important for investors interested in comparing IMNM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMNM versus a peer is one thing; comparing IMNM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMNM can fluctuate over the course of history. With this page we aim to empower investors researching IMNM by allowing them to research the IMNM market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree IMNM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Immunome (IMNM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IMNN Market Cap History
IMNP Market Cap History
IMPL Market Cap History
IMRA Market Cap History
IMRX Market Cap History
IMUX Market Cap History
IMV Market Cap History
IMVT Market Cap History
INAB Market Cap History
INBS Market Cap History
More Healthcare companies »

 

IMNM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.